Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Metastases to peritoneum
ADR ID BADD_A05055
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.02      Metastases to specified sites
16.22.02.008      Metastases to peritoneum
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.03      Malignant miscellaneous gastrointestinal neoplasms
07.21.03.003      Metastases to peritoneum
Description Tumors or cancer of the PERITONEUM. [MeSH]
MedDRA Code 10051676
MeSH ID D010534
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Peritoneal metastases | Metastases to peritoneum | Peritoneal carcinomatosis | Peritoneal dissemination | Peritoneal Neoplasms | Neoplasm, Peritoneal | Peritoneal Neoplasm | Peritoneal Surface Malignancy | Malignancy, Peritoneal Surface | Peritoneal Surface Malignancies | Surface Malignancy, Peritoneal | Peritoneal Carcinomatosis | Carcinomatosis, Peritoneal | Peritoneal Carcinomatoses
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00142Anastrozole0.000397%
BADD_D00330Cabozantinib0.000795%
BADD_D00349Capecitabine0.000448%
BADD_D00364Carboplatin0.000280%
BADD_D00474Cisplatin0.000112%
BADD_D00566Dabrafenib0.000112%
BADD_D00723Doxorubicin0.000168%
BADD_D00800Erlotinib0.000728%
BADD_D00858Everolimus0.000764%
BADD_D00979Furosemide0.000014%
BADD_D01136Imatinib0.000951%
BADD_D01257Letrozole0.001185%
BADD_D01352Maraviroc--
BADD_D01401Metformin0.000011%
BADD_D01601Olaparib0.000895%
BADD_D01629Osimertinib0.000224%
BADD_D01633Oxaliplatin0.000280%
BADD_D01653Paclitaxel0.000224%
BADD_D01687Pazopanib0.000336%
BADD_D01783Pirfenidone0.000241%
BADD_D01922Regorafenib0.001007%
BADD_D02029Sitagliptin0.000239%
BADD_D02058Sorafenib0.000560%
BADD_D02100Sunitinib0.000112%
BADD_D02344Vemurafenib0.000224%
BADD_D02412Octreotide0.000559%
BADD_D02464Fingolimod0.000482%
BADD_D02568Lutetium oxodotreotide lu-177-
BADD_D02591Ripretinib0.000112%
BADD_D02629Niraparib--
The 1th Page    1    Total 1 Pages